Recalls and suspensions

Subscribe to TGA safety information
14 February 2020
Product defect correction - potential for blank labelling to pose risk of accidental misuse
29 November 2019
Recall - bacterial contamination of one batch
14 November 2019
Product defect correction – risk of delayed therapy due to potential battery issues
5 September 2019
Recall - potential toxicity (金 匮 肾 气 丸 - statement includes Chinese translation 中文翻译)

More safety information »

Safety information

Subscribe to TGA safety information
3 April 2020
Mojo Black capsules pose a serious risk to your health and should not be taken
1 April 2020
Safety advisory - alternative product filling shortage may cause airway irritation if administered via inhalation
27 March 2020
We have investigated a report that intravenous high-dose vitamin C may be beneficial in the management of COVID-19
24 March 2020
Only certain types of specialists will be able to prescribe hydroxychloroquine to new patients

More safety information »


Subscribe to TGA latest news and updates
4 April 2020
A list of tests approved for inclusion on the Australian Register of Therapeutic Goods (ARTG).
3 April 2020
The TGA has issued ATP Science Pty Ltd with 24 infringement notices
3 April 2020
Poisons Standard amendments to hydroxychloroquine to ensure continued availability during the COVID-19 pandemic
2 April 2020
Information about the steps we are taking to make sure there are enough ventilators to match demand during the COVID-19 pandemic

More news »